自由飞加速器7天试用-快连加速器app
DECIPHER is used by the clinical community to share and compare phenotypic and genotypic data. The DECIPHER database contains data from 36,608 patients who have given consent for broad data-sharing; DECIPHER also supports more limited sharing via consortia. Have a look at the numbers.
Anyone can browse publicly-available patient data on DECIPHER and request to be put in contact with the responsible clinician. Why? Because sharing benefits everyone.
自由飞加速器7天试用-快连加速器app
Projects affiliated to DECIPHER can deposit and share patients, variants, and phenotypes to invite collaboration and facilitate diagnosis. Once deposited, you can use DECIPHER to identify and prioritise potential matches, and you can request notifications as soon as new matches arrive.
As well as influencing individual patient outcomes, use of DECIPHER has contributed to over 2200 published articles since 2004. It's still free, and you are in control of what data to make public.
自由飞加速器7天试用-快连加速器app
自由飞加速器7天试用-快连加速器app
LOADING...
For more news about DECIPHER, click 海豚加速器破解版2022.
自由飞加速器7天试用-快连加速器app
DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans using Ensembl Resources. Firth, H.V. et al., 2009. Am.J.Hum.Genet 84, 524-533 (DOI: dx.doi.org/10/1016/j.ajhg.2009.03.010)
Authors who use data from the project must acknowledge DECIPHER using the following wording: "This study makes use of data generated by the DECIPHER community. A full list of centres who contributed to the generation of the data is available from http://6mrpty.wcbzw.com and via email from decipher@sanger.ac.uk. Funding for the project was provided by Wellcome."
Please see Citing DECIPHER for more information.